- Home
- EFSC vs BCRX Comparison
EFSC vs BCRX Comparison
Compare EFSC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFSC | BCRX |
|---|---|---|
| Founded | 1988 | 1986 |
| Country | United States | United States |
| Employees | 1418 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | EFSC | BCRX |
|---|---|---|
| Price | $58.25 | $9.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $66.33 | $20.82 |
| AVG Volume (30 Days) | 230.1K | ★ 4.3M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $14.22 | N/A |
| Revenue Next Year | $3.77 | $12.55 |
| P/E Ratio | $11.50 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $50.88 | $6.00 |
| 52 Week High | $62.20 | $11.31 |
Technical Indicators
Market Signals| Indicator | EFSC | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.82 | 48.90 |
| Support Level | $56.78 | $8.73 |
| Resistance Level | $59.54 | $9.40 |
| Average True Range (ATR) | 1.30 | 0.48 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 31.31 | 59.95 |
Price Performance
Historical ComparisonAbout EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Its Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.